NE BUSINESS BUREAU
AHMEDABAD, AUG 25
Kolkata-based Medwin Healthcare on Tuesday announced the virtual launch of a device which, it claimed, has the ability to contain the spread of coronavirus. The device, Shycocan (Scalene Hypercharge Corona Canon), has been invented by Rajah Vijay Kumar who is Chairman & Chief Scientific Officer, Organization de Scalene, and Scalene Cybernetics Ltd, a Bengaluru-based company.
The company is the international humanitarian agreement holder to manufacture and market Shycocan for India as well as for the entire South Asia, it added.
“Shycocan is proven to be 99.9 per cent effective in neutralising the Spike-Protein or S-protein that are present in coronavirus…We have received approvals from the US Food and Drug Administration (USFDA) and the European Union Confirmite Europenne (CE),” Kumar said.
Speaking on the workings of the device, Dr Rajah Vijay Kumar iterated, “SHYCOCAN is proven to be 99.9% effective in neutralising the Spike-Protein or S-protein that are present in coronavirus. The device is designed to release a very high concentration of environmentally safe electrons using proprietary Photon-Mediated Electron Emitters (PMEEs) made with a superalloy developed by us, to emit and excite photons with the required kinetic energy. As the high energy photons bombard bulk surfaces and suspended particles in confined environments, the electron cloud actively ‘disarms’ air and surface transmission of the Corona family of viruses. Even if an infected individual were to walk into the room, these electrons would neutralise the potency of the virus present in aerosols while sneezing or coughing. We have received approvals from the US Food and Drug Administration (FDA) and the European Union Confirmite Europenne.”
The product has fulfilled the conditions laid down by European Union- CE and it is market enabled as per the USFDA’s enforcement discretion guidance during the COVID-19 Public Health Emergency, Kumar added.
“Medwin Healthcare will manufacture and market this device not only for the people in India but for the world at large,” Medwin Healthcare CEO Debashis Bose said while addressing the virtual launch of the device. The company will first dispatch the product to hospitals, clinics and other frontline warriors, he added.
“The production has already started and we are increasing it everyday. We are going to start despatching the product from the end of this month. So far 1,600 units have been manufactured out of which 500 have already been distributed. We are planning to produce at least 1,30,000 devices within the next six months”, Bose said.
The device is priced at Rs 19,999 inclusive of 18 per cent GST, he added.
Dhrubajyoti Bose, CFO, Medwin Healthcare further added, “SHYCOCAN will enable us to create a safer environment in homes, offices, healthcare facilities, schools, eateries, etc. The device has been priced, keeping in mind, that the maximum strata of our society can afford it. This Made in India, By Indians, device is bound to bring some respite. This will eventually result in lower coronavirus positive cases and help in flattening of the curve. It is a positive step towards the vision laid out by our Prime Minister Narendra Modi about Atmanirbhar Bharat.”
It works on a plug & play mode. Medwin Healthcare has two manufacturing units in Kolkata and one in Bangalore, Pune, and Gurugram and will eventually start the distribution across the country and has plans to go abroad.
.
